Announce Date | 07/23/2025 |
EPS Normalized Actual | $2.04 (Beat by $0.05) |
EPS GAAP Actual | $2.04 (Beat by $0.05) |
Revenue Actual | $1.61623B |
Revenue Surprise | Beat by $1616.23M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $4.61492 |
EPS GAAP Estimate | $4.61492 |
Revenue Estimate | $1.494052478B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 29.66 | 2.63 | 28.39275 | 31.03433 | 1 |
Dec 2027 | 26.73 | 2.92 | 25.58794 | 27.96856 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.05 | -2.54266 | 1.61623B | -4.8% | 76.67M |
FQ1 2025 (Mar 2025) | 1.71 | 1.71 | 1.36528B | -7.55% | 1365.28M |
FQ4 2024 (Dec 2024) | 4.78 | 4.78 | 1.61328B | -2.47% | 1613.28M |
FQ3 2024 (Sep 2024) | 5.41 | 5.41 | 1.58845B | -1.55% | 1588.45M |
FQ2 2024 (Jun 2024) | 6.38 | 6.38 | 1.69374B | 7.43% | 1693.74M |
FQ1 2024 (Mar 2024) | 5.12 | 5.12 | 1.4684B | 12.47% | 1468.4M |
FQ4 2023 (Dec 2023) | 5.46 | 5.46 | 1.6532B | -20.46% | 1653.2M |
FQ3 2023 (Sep 2023) | 6.06 | 6.06 | 1.6131B | 2.17% | 1613.1M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
4.61492
Consensus Revenue Estimates
1.494052478B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.28431 | -- | 2.26804 | 2.29424 | 7 |
FQ3 2027 (Sep 2027) | 3.25188 | -- | 2.95126 | 3.4101 | 2 |
FQ2 2027 (Jun 2027) | 2.96725 | -- | 2.69295 | 3.11162 | 2 |
FQ1 2027 (Mar 2027) | 2.31944 | -- | 2.16095 | 2.42723 | 3 |
FQ4 2026 (Oct 2026) | 5.11135 | -- | 4.65289 | 5.79853 | 3 |
FQ3 2026 (Jul 2026) | 4.22064 | -- | 3.84207 | 4.78807 | 3 |
FQ2 2026 (Jun 2026) | 4.22346 | 51.46 | 3.82392 | 4.63979 | 4 |
FQ1 2026 (Mar 2026) | 3.19906 | 46.55 | 2.89643 | 3.51441 | 4 |
FQ4 2025 (Oct 2025) | 5.33821 | 10.46 | 4.8594 | 6.05589 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.73B | -- | 1.72B | 1.74B | 2 |
FQ3 2027 (Sep 2027) | 2.08B | -- | 1.94B | 2.16B | 2 |
FQ2 2027 (Jun 2027) | 1.94B | -- | 1.81B | 2.02B | 2 |
FQ1 2027 (Mar 2027) | 1.66B | -- | 1.57B | 1.71B | 3 |
FQ4 2026 (Oct 2026) | 1.7B | -- | 1.58B | 1.87B | 4 |
FQ3 2026 (Jul 2026) | 1.49B | -- | 1.39B | 1.65B | 6 |
FQ2 2026 (Jun 2026) | 1.58B | -2.57 | 1.46B | 1.7B | 4 |
FQ1 2026 (Mar 2026) | 1.31B | -4.14 | 1.22B | 1.41B | 7 |
FQ4 2025 (Oct 2025) | 1.7B | 5.21 | 1.58B | 1.88B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 4.59266 | 2.05 | -2.54266 | -124.03% |
FQ1 2025 (Mar 2025) | 1.71 | 1.71 | 100% | |
FQ4 2024 (Dec 2024) | 4.78 | 4.78 | 100% | |
FQ3 2024 (Sep 2024) | 5.41 | 5.41 | 100% | |
FQ2 2024 (Jun 2024) | 6.38 | 6.38 | 100% | |
FQ1 2024 (Mar 2024) | 5.12 | 5.12 | 100% | |
FQ4 2023 (Dec 2023) | 5.46 | 5.46 | 100% | |
FQ3 2023 (Sep 2023) | 6.06 | 6.06 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $1.54B | $1.62B | $76.67M | 4.74% |
FQ1 2025 (Mar 2025) | $0B | $1.37B | $1365.28M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.61B | $1613.28M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.59B | $1588.45M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.69B | $1693.74M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.47B | $1468.4M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.65B | $1653.2M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.61B | $1613.1M | 100% |